Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression: A Randomized Clinical Trial. | ClinicLens
Psilocybin has been proposed as a rapid-acting antidepressant (onset 6 weeks), but evidence from randomized clinical trials remains limited, particularly in the broader major depressive disorder (MDD) population. To assess short-term and long-term antidepressant effects of psiloc
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.